Cargando…

Novel Inflammasome-Based Risk Score for Predicting Survival and Efficacy to Immunotherapy in Early-Stage Non-Small Cell Lung Cancer

Immune checkpoint inhibitors (ICI) for early-stage non-small cell lung cancer (NSCLC) have been approved to improve outcomes and reduce recurrence. Biomarkers for patient selection are needed. In this paper, we proposed an inflammasome-based risk score (IRS) system for prognosis and prediction of IC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsao, Chih-Cheng, Wu, Hsin-Hung, Wang, Ying-Fu, Shen, Po-Chien, Wu, Wen-Ting, Chen, Huang-Yun, Dai, Yang-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313462/ https://www.ncbi.nlm.nih.gov/pubmed/35884843 http://dx.doi.org/10.3390/biomedicines10071539

Ejemplares similares

Establishment of tumor inflammasome clusters with distinct immunogenomic landscape aids immunotherapy
por: Liang, Qingyu, et al.
Publicado: (2021)

Targeting inflammasome/IL-1 pathways for cancer immunotherapy
por: Guo, Beichu, et al.
Publicado: (2016)

Number of negative lymph nodes with a positive impact on survival of stage III colon cancer; a retrospective observation study for right side and left side colon
por: Kuo, Yi-Hung, et al.
Publicado: (2022)

The ATP-P2X(7) Signaling Axis Is an Essential Sentinel for Intracellular Clostridium difficile Pathogen-Induced Inflammasome Activation
por: Liu, Ya-Hui, et al.
Publicado: (2018)

DNA vaccine for cancer immunotherapy
por: Yang, Benjamin, et al.
Publicado: (2015)

Lactate score predicts survival, immune cell infiltration and response to immunotherapy in breast cancer
por: Yin, Ting-Ting, et al.
Publicado: (2022)

Corrigendum: The ATP-P2X(7) Signaling Axis Is an Essential Sentinel for Intracellular Clostridium difficile Pathogen-Induced Inflammasome Activation
por: Liu, Ya-Hui, et al.
Publicado: (2019)

Living-Donor Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Score and Predictive Value of NLR on Survival
por: Hung, Hao-Chien, et al.
Publicado: (2022)

Validation of the Cardiac Arrest Survival Postresuscitation In-hospital (CASPRI) score in an East Asian population
por: Wang, Chih-Hung, et al.
Publicado: (2018)

Activation of an NLRP3 Inflammasome Restricts Mycobacterium kansasii Infection
por: Chen, Chang-Chieh, et al.
Publicado: (2012)

Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages
por: Lee, Po-Yen, et al.
Publicado: (2021)

Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection
por: Chen, Hsin-Chien, et al.
Publicado: (2017)

Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
por: Lai, Yin, et al.
Publicado: (2022)

Effects of Multidisciplinary Team Care on the Survival of Patients with Different Stages of Non-Small Cell Lung Cancer: A National Cohort Study
por: Pan, Chien-Chou, et al.
Publicado: (2015)

Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
por: Lo, Jung, et al.
Publicado: (2022)

Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
por: Karan, Dev
Publicado: (2018)

Alternative functions for the multifarious inflammasome
por: Martel, Jan, et al.
Publicado: (2016)

Propensity Score-Matched Analysis of the Survival Benefit from Kidney Transplantation in Patients with End-Stage Renal Disease
por: Wu, Ming-Ju, et al.
Publicado: (2018)

A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC)
por: Wu, Zhulin, et al.
Publicado: (2020)

Survival factors of hospitalized out-of-hospital cardiac arrest patients in Taiwan: A retrospective study
por: Lai, Chung-Yu, et al.
Publicado: (2018)

Immunotherapy for extensive stage small cell lung cancer
por: Pacheco, Jose M.
Publicado: (2020)

Immunotherapy in Extensive-Stage Small Cell Lung Cancer
por: El Sayed, Rola, et al.
Publicado: (2021)

Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome
por: Chang, Yu-Wei, et al.
Publicado: (2021)

Prolonged Survival in a Patient With Extensive-Stage Small Cell Lung Cancer in Spite of Discontinued Immunotherapy With Atezolizumab
por: Konishi, Kazuhisa, et al.
Publicado: (2023)

IFNγ score–based neoadjuvant immunotherapy for stage III melanoma
por: Fukuda, Keitaro
Publicado: (2023)

Development and Testing of the Smart Healthcare Prototype System through COVID-19 Patient Innovation
por: Chiu, Po-Chih, et al.
Publicado: (2023)

Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer
por: Xie, Zhaoliang, et al.
Publicado: (2023)

Factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer patients
por: Wu, Yahua, et al.
Publicado: (2021)

Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma
por: Ma, Jia-Lin, et al.
Publicado: (2021)

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
por: Lin, Chih-Wen, et al.
Publicado: (2020)

Pre-Immunotherapy Contrast-Enhanced CT Texture-Based Classification: A Useful Approach to Non-Small Cell Lung Cancer Immunotherapy Efficacy Prediction
por: Shen, Leilei, et al.
Publicado: (2021)

Prognostic Value of Tumor Size in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer
por: Chen, Chih-Yu, et al.
Publicado: (2020)

Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
por: Lin, Ting-Yi, et al.
Publicado: (2021)

Low-Dose Aspirin Use Significantly Improves the Survival of Late-Stage NPC: A Propensity Score-Matched Cohort Study in Taiwan
por: Luo, Sheng-Dean, et al.
Publicado: (2020)

Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation
por: Chu, Michelle Ong, et al.
Publicado: (2018)

Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
por: Dai, Yang-Hong, et al.
Publicado: (2021)

Effect of immunotherapy on overall survival in limited-stage small cell lung carcinoma: a national cancer database analysis
por: Bilani, Nadeem, et al.
Publicado: (2021)

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer
por: Zhang, Shuang, et al.
Publicado: (2021)

Prediction of Severe Neonatal Hyperbilirubinemia Using Cord Blood Hydrogen Peroxide: A Prospective Study
por: Chou, Hung-Chieh, et al.
Publicado: (2014)

NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score
por: Song, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aqc9kvmhi09mqn0hf996uueg69